Third Arc Bio: Latest News, Top Stories & Analysis

SPRING HOUSE, PA — Third Arc Bio Inc. has closed a $52 million extension of its Series A financing, adding fresh firepower to a previously announced $165 million raise as …

Regional

Third Arc Bio Enters Clinical Stage with First Patient Dosed in ARC101 Study

March 16, 2025March 15, 2025 - by Timothy Alexander

SPRING HOUSE, PA — Third Arc Bio Inc. has administered the first dose of ARC101 to a patient in its inaugural first-in-human clinical trial. This milestone marks the company’s transition to …